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INTRODUCTION
The natural course of acute necrotizing pancreatitis
progresses in two phases. The first 14 days are char-
acterized by the systemic inflammatory response
syndrome resulting from the release of inflammatory
mediators. The second phase, beginning approximately
2 weeks after the onset of the disease, is dominated by
sepsis-related complications resulting from infection of
pancreatic and peripancreatic necrosis; and late in the
second phase, about 4 weeks after the onset, systemic
OBJECTIVE: This study was conducted to assess the rapid diagnosis of fungal infections in patients
with acute necrotizing pancreatitis by polymerase chain reaction (PCR) using universal primers
targeting the 18S rRNA gene.
METHODS: In this study, a PCR assay was developed to identify clinically isolated fungi, and both
PCR technique and conventional culture were used to detect fungi in 37 samples from patients with
acute necrotizing pancreatitis.
RESULTS: A 197-bp fragment was amplified by PCR from all the clinically isolated fungal strains. This
fragment was not isolated from gram-positive, gram-negative bacteria or human leucocytes. Thirty-
seven samples of necrotic tissue or peripancreatic fluid from 11 patients were also analyzed, and eight
samples were positive for fungi by PCR, six of which were also positive by conventional culture. The
whole PCR procedure was completed within 7 hours.
CONCLUSION: PCR can be used to diagnose fungal infection secondary to acute necrotizing
pancreatitis rapidly and sensitively. (Asian J Surg 2002;25(3):209–13)
fungal infection ensues in a certain percentage of patients.1,2
The clinical presentation of fungal infection in acute
necrotizing pancreatitis is often nonspecific and laboratory
diagnosis is often delayed due to the relatively slow
growth of these yeasts from clinical specimens. As a
result, the current culture-based diagnostic methods are
often limited to detection of the organism in patients at an
advanced stage of disease. The clinician must often make
an empiric therapeutic decision and administer
prophylactic antifungal drugs before culture results are
obtained.3 Earlier detection of infection would permit
prompt initiation of antifungal therapy with a greater
likelihood for improved survival and reduced morbidity.
Rapid identification of fungal infection would, therefore,
be clinically helpful. Identification of minute quantities
of fungus-specific DNA has been made possible by using
polymerase chain reaction (PCR) techniques. The current
study was conducted to evaluate the technique of using
PCR with universal primers targeting fungal 18S rRNA
genes to facilitate earlier diagnosis of fungal infection in
patients with acute necrotizing pancreatitis.
Address reprint requests to Dr. Wei-Zhong Zhang,
Department of Surgery, Taizhou First Hospital,
Taizhou, Zhejiang Province,
People's Republic of China 318020.
Email: zhangweizhong11@hotmail.com
Date of acceptance:  10th April 2002
Vol 25 • No 3 • July 2002210
ZHANG AND OTHERS
MATERIALS AND METHODS
Patients and clinical specimens
Patients were enrolled in this study when they met
both of the following conditions: 1) acute necrotizing
pancreatitis confirmed by computed tomography (CT) or
surgery according to the Atlanta criteria, and 2) clinical
course more than 4 weeks. Between May 1998 and May
1999, 11 patients conforming to the inclusion criteria
were admitted into the surgical department of Ruijin
Hospital, Shanghai, and nine patients underwent necro-
sectomy. Thirty-seven clinical samples including
32 peripancreatic fluid and five necrotic tissue samples
were obtained intraoperatively, during wound
debridement or by fine needle aspiration under CT
guidance. The average age of the patients was 56.0 ±
9.3 years. Eight of the patients were male and three were
female; their average APACHE II score was 9.8 ± 3.3 points.
DNA extraction of fungal isolates
Fungal isolates including Candida species, Aspergillus
species, Pseudallescheria boydii and Cryptococcus
neoformans from the Department of Clinical Diagnosis of
the Ruijin Hospital were obtained. These fungal isolates
were recovered from patients with acute necrotizing
pancreatitis,2 and were cultured onto Sabouraud dextrose
agar slants, incubated at 37°C overnight and maintained at
4°C. Cultured fungal cells (50 µL) were prepared in
100 µL of spheroplast buffer (1.0 M sorbitol, 50.0 mM
sodium phosphate monobasic, 0.1% 2-mercaptoethanol,
10 µ/mL lyticase). Pellets were suspended for 30 minutes at
56°C. After centrifugation for 5 minutes at 10,000 rpm, the
supernatant was discarded and the sediment was preserved.
The sediment was then lysed in 10% chelex-100 (Sigma, St.
Louis, MO, USA), 0.03% sodium dodecyl sulfate, 1%
Tween 20, 1% Nonidetp-40 for 5 minutes at 95°C. After
centrifugation (5,000 rpm) for 10 seconds, 5 µL of the
supernatant was directly used for PCR amplification.4,5
DNA extraction of clinical samples
Peripancreatic fluid or necrotic tissue samples were
diluted with double-distilled H2O. Fungal DNA (0.5ml)
samples were transferred into 1.5 ml sterile Eppendorf
tubes, and centrifugated at 3,000 rpm for 1 minute. The
resulting sediment was preserved and lysed in 1 ml of
spheroplast buffer for further DNA extraction.
DNA extraction of human leucocytes
First, 2 ml of blood from healthy volunteers were
drawn into Na2EDTA tubes, then 1 ml of blood was
transferred from the Na2EDTA tubes to sterile 1.5 ml
Eppendorf tubes. Red cells were lysed in 0.32 M of sugar,
5 mmol of MgCl2, 0.01 M of Tris-Cl, 1% Triton-X for 10
minutes at room temperature.5 After centrifugation for 5
minutes at 5,000 rpm, the supernatant was discarded and
the sediment was treated as above.
DNA extraction from bacterial isolates
Bacterial isolates including Escherichia coli and
Staphylococcus aureus were provided by the Department
of Clinical Diagnosis and cultured conventionally. The
cells were prepared in 10% chelex-100 (Sigma), 0.03%
sodium dodecyl sulfate, 1% Tween-20, 1% Nonidetp-40
for 5 minutes at 95°C for DNA extraction.5
Positive and negative controls
DNA from clinical isolates of Candida albicans was
extracted in the same manner as outlined previously. This
DNA was used to determine if the PCR reaction was
successful. In addition to a positive control, each PCR
experiment contained a reagent, negative control that
consisted of all PCR reagents, but without DNA, to
determine the presence of contamination.
Amplification of extracted DNAs
PCR was performed in 50 µL of reaction mixture (MJ,
Research, INC, New York, USA). The final PCR mixture
consisted of 35.5 µL of double-distilled water, 4.0 µL of
a deoxynucleoside triphosphate (dNTP) mixture (0.08
mM for each dNTP), 2.0 µL of primer 1, 2.0 µL of primer
2, 5.0 µL of 10 x concentrated PCR buffer (15 mM MgCl2,
500 mM KCl, 100mM Tris-HCl, and 0.01% gelatin), and
0.5 µL of Taq polymerase (Sigma, Shanghai, PRC).
Amplification by PCR was performed under standard
reaction conditions: one cycle of 94°C for 5 minutes,
55°C for 1 minute, and 72°C for 2 minutes; 29 cycles of
94°C for 1 minute, 55°C for 1 minute, and 72°C for 2
minutes; 1 cycle of 94°C for 1 minute, 55°C for 1 minute,
and 72°C for 7 minutes; and a 4°C soak. Oligonucleotides
used as primers in this study were AGC TCT TTC TTG
ATT TTG TGG and GCA TCA CAG ACC TGT TAT TGC
CTC, which amplify a 197-bp segment of a small nuclear
rRNA fungal gene.4
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Identification of PCR products
After amplification, 2 µL of PCR products were
electrophoresed on 2% agarose gel at 60 V for 60 minutes.
DNA bands were detected by ethidium bromide staining
and visualized by UV light photography.
Culture of clinical specimens
Necrotic tissues were minced in a sterile environment
and peripancreatic fluid specimens over 2 ml in volume
were concentrated by centrifugation. Following this, the
specimens were inoculated onto Sabouraud agar slants
and incubated at 37°C for an average of 5 days.
RESULTS
PCR detection of fungal isolates
Isolates of Candida spp. including albicans (n = 30),
tropicalis (n = 23) and parapsilosis (n = 3), isolates of
Aspergillus spp. including A. fumigatus (n = 14), A. flavus
(n = 2), isolates of P. boydii (n = 2) and C. neoformans
(n = 1) (provided by Department of Clinical Diagnosis,
Ruijin Hospital) were studied. DNA samples were
extracted, PCR amplification performed and a 197-bp
band was identified (Figure).
PCR detection of bacterial and human
leucocyte DNA
DNA from human leucocytes, S. aureus and E. coli
were extracted and PCR amplification was completed.
No 197-bp band was identified.
Fungal detection in clinical specimens
Thirty-two samples of peripancreatic fluid and five
samples of necrotic tissue (37 in total) were collected from
Figure. Agarose gel electrophoresis of fungal DNA from
clinical isolates. Lane 1, DNA marker; lane 2, Aspergillus
fumigatus; lane 3, Aspergillus flavus; lane 4, Candida albicans;
lane 5, Candida tropicalis.
Table. Detection results of 14 clinical samples by PCR and culture
Case Samples Culture PCR Clinical outcome
1 Peripancreatic fluid Candida albicans +
Peripancreatic fluid - +
Peripancreatic fluid - -
Peripancreatic fluid - -
Peripancreatic fluid - - survived
2 Peripancreatic fluid Candida albicans +
Peripancreatic fluid Candida albicans +
Peripancreatic fluid Candida albicans +
Peripancreatic fluid - +
Peripancreatic fluid - -
Peripancreatic fluid - - survived
3 Necrotic tissue - -
Peripancreatic fluid Candida albicans +
Peripancreatic fluid Candida albicans + died
Data were time-ordered in the same patient. The remaining 23 samples from eight patients were both PCR and culture negative.
1 2 3 4 5
197 bp
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11 patients. Fungal DNA was extracted and amplified as
above and clinical samples were sent for conventional
cultures simultaneously. The necrotic tissues were negative
for fungus by both conventional culture and PCR. Eight
out of 32 peripancreatic fluid samples were positive for
fungus on PCR, yielding a 197-bp band. Six were culture-
positive and two culture-negative. The fungi recovered
were C. albicans. The eight samples positive for fungus on
PCR were derived from three patients. Six of the culture-
positive samples also came from the same three patients
(Table). The remaining 24 peripancreatic fluid samples
were both PCR- and culture-negative. Sensitivity and
specificity of PCR detection were 100% and 93.5%,
respectively.
DISCUSSION
Late in the second phase of the natural course of acute
necrotizing pancreatitis (i.e., 4 weeks after onset), systemic
fungal infection occurs in some patients, mainly as a result
of the prophylactic use of broad-spectrum antibacterial
agents, including third-generation cephalosporins and
imipenem, which suppress the intestinal bacterial flora
and allow the proliferation of fungi within the
gastrointestinal tract.1,2 However, the diagnosis of fungal
infection is problematic, as the clinical presentation can
be rather variable and nonspecific. Fever occurs in up to
80% of cases and leukocytosis in up to 50%. Patients with
fungal infection may not immediately appear to be seriously
ill, whilst others may present with septic shock.3 The
diagnostic standard is conventional fungal culture, but for
urine, aspirate, tissue and respiratory specimens, at least
95% of the isolates that were ultimately recovered had
become evident by day 7, and the rate of recovery at 7
days was slightly lower for cerebrospinal fluid (93%),
stool (91%), and nose, mouth, and sinus specimens
(90%), due to the relatively slow growth of these yeasts
from clinical specimens.6 Therefore, early detection and
identification of fungi is critical for the proper targeting of
antifungal therapy.
Universal primers common to all fungi have been used
as a promising approach for clinical diagnosis. The 18S
rRNA sequence is highly conserved through the
phylogenetic tree. This conserved sequence of the 18S
rRNA has led to the development of conserved primers for
PCR for the detection of fungi.4,7 In this study, we developed
a fungal PCR assay, including fungal DNA extraction,
PCR amplification, identification of PCR products, PCR
contamination monitoring via negative and positive controls.
A heavy wall surrounds the fungal cell, and this cell
wall should be destroyed before DNA extraction with
lyticase at 56°C for 30 minutes. Fungal pellets were then
lysed in 10% chelex-100 (Sigma), 0.03% sodium dodecyl
sulfate, 1% Tween-20, 1% Nonidetp-40 for 5 minutes at
95°C for DNA extraction, and the prepared DNA was
amplified directly.
The whole process of DNA extraction required less
than 1 hour, while DNA amplification took 3.5 hours.
One hour was needed for identification. The whole
procedure was completed within 7 hours, in contrast
to a mean of 5 days by routine identification methods.
Other advantages of this PCR assay include a simple
DNA extraction method, and no interference in the
detection of yeasts in samples containing bacteria,
compared with conventional culture which could be
affected by overgrowth of bacteria. Because of the
minute quantity of reaction reagents used in the
detection, the cost of PCR diagnosis is comparable to
that of conventional culture.
In our study, we detected by PCR assay the fungal
isolates commonly identified in patients with acute
necrotizing pancreatitis, positive PCR assays yielding the
197-bp DNA product. At the same time, samples from
healthy human leucocytes, S. aureus and E. coli were
negative by PCR and no detectable PCR amplicon was
demonstrated by gel electrophoresis and EB staining,
suggestive of high specificity.
Thirty-seven samples were collected and under-
went both conventional culture and PCR assay. Eight
samples were positive for fungal DNA on PCR, of which
six were also culture-positive. The culture-positive
samples were obtained from three patients, and antifungal
drugs such as fluconazole or amphotericin B were initiated
as soon as the PCR results were obtained. One patient
died from multi-organ failure. With each PCR assay of
clinical samples, a negative control was employed to
safeguard against the potential contamination of the
stock PCR reagent with fungal DNA products in the
environment, and this study showed no false-positive
results, which signified that the PCR results for clinical
samples were reliable. Therefore, as long as the envir-
onmental contamination is controlled, it is practical that
the PCR test can be used in peripheral non-teaching
hospitals.
The two PCR-positive but culture-negative samples
came from patients treated with amphotericin B. Before
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antifungal treatment, both amplification and culture were
positive. Two weeks following antifungal treatment,
samples were again collected for PCR and culture
detection: PCR was positive but culture was negative in
one patient, while the other patient had positive results
by both detection methods. Antifungals were continued
for another 7 days, after which both PCR and culture
were negative in the former patient. After another 10 days
of amphotericin B administration, the second patient had
both PCR- and culture-negative samples. Flahaut et al
reported two false-positive PCR samples from patients
treated with azole antifungal agents, both samples being
positive for culture before the initiation of antifungal
treatment.8 One may conclude from this that PCR is
probably able to detect damaged or inhibited organisms
resulting from antifungal treatment that would not
otherwise be recovered by culture.
In conclusion, the PCR assay using universal primers
targeting 18S rRNA gene can rapidly and sensitively
diagnose fungal infection secondary to acute necrotizing
pancreatitis. Further study using large samples is under
way to confirm this conclusion.
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